StockWatch
·
Pharmaceuticals
Corporate Governance10 Oct 2026, 03:28 pm

Advik Laboratories: Zero Investor Complaints in Q2 FY27

AI Summary

Advik Laboratories Ltd has reported its investor complaint status for the quarter ended September 30, 2026. As per SEBI regulations, the company has provided a statement detailing the number of complaints. For the quarter, there were zero complaints pending at the beginning, zero received during the quarter, zero disposed of, and zero remaining unresolved at the end of the period. This indicates effective grievance redressal mechanisms for the quarter.

Key Highlights

  • No investor complaints received during the quarter.
  • No investor complaints pending at the beginning of the quarter.
  • No investor complaints unresolved at the end of the quarter.
  • Company adheres to SEBI LODR Regulations for investor grievance reporting.